Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Other Non Operating Income data on record, last reported at $4.1 million in Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 9455.81% year-over-year to $4.1 million; the TTM value through Sep 2025 reached -$4.1 million, down 74.13%, while the annual FY2024 figure was -$2.3 million, 75.09% down from the prior year.
  • Other Non Operating Income reached $4.1 million in Q4 2025 per MRVI's latest filing, up from -$71000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $4.1 million in Q4 2025 and bottomed at -$4.1 million in Q2 2025.
  • Average Other Non Operating Income over 5 years is -$149166.7, with a median of $46000.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: plummeted 6766.67% in 2022, then surged 9455.81% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $201000.0 in 2021, then skyrocketed by 354.73% to $914000.0 in 2022, then tumbled by 94.64% to $49000.0 in 2023, then fell by 12.24% to $43000.0 in 2024, then soared by 9455.81% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $4.1 million in Q4 2025, -$71000.0 in Q3 2025, and -$4.1 million in Q2 2025.